• Inhibin A and B, Tumor Marker
  • Chromosome Breakage Study, Bone Marrow
  • Branched-chain-ketoacid dehydrogenase (BCKDH) Gene Mutation Analysis
  • Platelet Antibodies, Serum
  • Autopsy
  • UBE3A Gene Mutation Analysis, Angelman Syndrome, Blood
  • Melanocytic nevus
  • CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • Collagen Type II, Antibody
  • Osmolality, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Turnaround Time
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.